BiotechTube
Home/Spirair/Andy Uchida
AU

Andy Uchida

Executive Vice President, R&D and Operations

Spirair

Therapeutic Areas

RespiratoryOtolaryngology

Spirair Pipeline

DrugIndicationPhase
SeptAlignMinor Nasal Septal Deviation (NSD)Approved
TurbAlignTurbinate Hypertrophy/MedializationPre-commercial

Leadership Team at Spirair

BB
Ben Bishop
Chief Executive Officer
JK
James Kintzing, PhD
Co-founder & Chief Technology Officer
BM
Brandon McCutcheon, MD
Co-founder & Chief Medical Officer
PP
Paul Praino
VP of Sales
TH
Tracey Henry
Vice President, Clinical, Quality & Regulatory
View full Spirair profile